Traumatic brain injury increases β-amyloid peptide 1-42 in cerebrospinal fluid

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2505-2509

  Raby, Charlotte A ^a   Morganti Kossmann, Maria C ^d   Kossmann, Thomas ^d   Stahel, Philip F ^d   Watson, M Desiree ^a   Evans, Lori M ^a   Mehta, Pankaj D ^b   Spiegel, Katharyn ^a   Kuo, Yu Min ^c   Roher, Alex E ^c   Emmerling, Mark R ^a  

^a PFIZER INC   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; Brain; CSF; Head trauma; Injury; Risk factors; Amyloid precursor protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK FACTOR;

EID: 0031741753     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062505.x     Document Type: Article

References (33)

1. Carroll R. T., Lust M. R., Kim K. S., Doyle P. D., and Emmerling M. R. (1995) An age-related correlation between levels of β-amyloid precursor protein and β-amyloid in human cerebrospinal fluid. Biochem. Biophys. Res. Commun. 210, 345-349.
2. Chyung A. S. C., Greenberg B. D., Cook D. G., Doms R. W., and Lee V. M. (1997) Novel β-secretase cleavage of β-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells. J. Cell Biol. 138, 671-680.
3. Diamond P. T. (1996) Brain injury in the Commonwealth of Virginia: an analysis of Central Registry data, 1988-1993. Brain Inj. 10, 413-419.
4. Frautschy S. A., Yang F., Calderon L., and Cole G. M. (1996) Rodent models of Alzheimer's disease: rat Aβ infusion approaches to amyloid deposits. Neurobiol. Aging 17, 311-321.
5. Gentleman S. M., Greenberg B. D., Savage M. J., Noori M., Newman S. J., Roberts G. W., Griffin W. S., and Graham D. I. (1997) Aβ42 is the predominant form of amyloid β-protein in the brains of short-term survivors of head injury. Neuroreport 8, 1519-1522.
6. Ghersi-Egea J. F., Gorevic P. D., Ghiso J., Frangione B., Patlak C. S., and Fenstermacher J. D. (1996) Fate of cerebrospinal fluid-borne amyloid β-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J. Neurochem. 67, 880-883.
7. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159.
8. Hartmann T., Bieger S. C., Bruhl B., Tienari P. J., Ida N., Allsop D., Roberts G. W., Masters C. L., Dotti C. G., Unsicker K., and Beyreuther K. (1997) Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nat. Med. 3, 1016-1020.
9. Hilbich C., Monning U., Grund C., Masters C. L., and Beyreuther K. (1993) Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J. Biol. Chem. 268, 26571-26577.
10. Ida N., Hartmans T., Pantel J., Schröder J., Zerfass R., Förstl H., Sandbrink R., Masters C. L., and Beyreuther K. (1996) Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay. J. Biol. Chem. 271, 22908-22914.
11. Jennett B. and Bond M. (1975) Assessment of outcome after severe brain damage. Lancet 1, 480-484.
12. Jordan B. D., Relkin N. R., Ravdin L. D., Jacobs A. R., Bennett A., and Gandy S. (1997) Apolipoprotein E ∈4 associated with chronic traumatic brain injury in boxing. JAMA 278, 136-140.
13. Kim K. S., Wen G. Y., Bancher C., Chen C. M. J., Saplenza V. J., Hong H., and Wisniewski H. M. (1990) Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7, 113-124.
14. Kossmann T., Hans V. H., Imhof H. G., Stocker R., Grob P., Trentz O., and Morganti-Kossmann C. (1995) Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 4, 311-317.
15. Kossmann T., Hans V., Imhof H. G., Trentz O., and Morganti-Kossmann M. C. (1996) Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713, 143-152.
16. Kossmann T., Stahel P. F., Lenzlinger P. M., Redl H., Dubs R. W., Trentz O., Schlag G., and Morganti-Kossmann M. C. (1997) Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J. Cereb. Blood Flow Metab. 17, 280-289.
17. Marshall L. F., Marshall S. B., Klauber M. R., Clark M. V. B., Eisenberg H. M., Jane J. A., Luerssen T. G., Marmarou A., and Foulkes M. (1991) A new classification of head injury based on computerized tomography. J. Neurosurg. 75, S14-S20.
18. Martel C. L., Mackic J. B., Matsubara E., Governale S., Miguel C., Miao W., McComb J. G., Frangione B., Ghiso J., and Zlokovic B. V. (1997) Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid β. J. Neurochem. 69, 1995-2004.
19. Mayeux R., Ottman R., Maestre G., Ngai C., Tang M. X., Ginsberg H., Chun M., Tycko B., and Shelanski M. (1995) Synergistic effects of traumatic head injury and apolipoprotein-∈4 in patients with Alzheimer's disease. Neurology 45, 555-557.
20. McKenzie K. J., McLellan D. R., Gentleman S. M., Maxwell W. L., Gennarelli T. A., and Graham D. I. (1996) Is β-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol. (Berl.) 92, 608-613.
21. Mehta P. D., Dalton A. J., Mehta S., Kim K. S., Sersen E. A., and Wisniewski H. M. (1998) Increased plasma amyloid β protein 1-42 levels in Down syndrome. Neurosci. Lett. 241, 13-16.
22. Motter R., Vigo-Pelfrey C., Kholodenko D., Barbour R., Johnson-Wood K., Galasko D., Chang L., Miller B., Clark C., Green R., et al. (1995) Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 38, 643-648.
23. Nakamura T., Shoji M., Harigaya Y., Watanabe M., Hosoda K., Cheung T. T., Shaffer L. M., Golde T. E., Younkin L. H., and Younkin S. G. (1994) Amyloid βprotein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Ann. Neurol. 36, 903-911.
24. Roberts G. W., Gentleman S. M., Lynch A., and Graham D. I. (1991) βA4 amyloid protein deposition in brain after head trauma. Lancet 338, 1422-1423.
25. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
26. Schofield P. W., Tang M., Marder K., Bell K., Dooneief G., Chun M., Sano M., Stern Y., and Mayeux R. (1997) Alzheimer's disease after remote head injury: an incidence study. J. Neurol. Neurosurg. Psychiatry 62, 119-124.
27. Selkoe D. J. (1994) Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell. Biol. 10, 373-403.
28. Stocker R., Bernays R., Kossmann T., and Imhof H. G. (1995) Monitoring and treatment of acute head injury, in The Integrated Approach to Trauma Care (Goris R. J. A. and Trentz O., eds), pp. 197-210. Berlin, Springer-Verlag.
29. Tamaoka A., Sawamura N., Fukushima T., Shoji S., Matsubara E., Shoji M., Hirai S., Furiya Y., Endoh R., and Mori H. (1997) Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. Neurol. Sci. 148, 41-45.
30. Teasdale G. and Jennett B. (1974) Assessment of coma and impairment consciousness: a practical scale. Lancet 2, 81-84.
31. Tienari P. J., Ida N., Ikonen E., Simons M., Weidemann A., Multhaup G., Masters C. L., Dotti C. G., and Beyreuther K. (1997) Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 94, 4125-3410.
32. Turner R. S., Suzuki N., Chyung A. S., Younkin S. G., and Lee V. M. (1996) Amyloids β40 and β42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271, 8966-8970.
33. Wild-Bode C., Yamazak I. T., Capell A., Leimer U., Steiner H., Ihara Y., and Haass C. (1997) Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42. J. Biol. Chem. 272, 16085-16088.